Abstract
The aim of this study was to evaluate the association of overweight, obesity, excess central adiposity, hyperglycemia, and diabetes mellitus with tumor characteristics in breast cancer. In this retrospective cohort study that enrolled 2127 women with breast cancer, the independent variables collected were fasting blood glucose, body mass index, central adiposity (waist circumference and waist-to-hip circumference ratio (WHR)), and waist-to-height ratio. The tumor characteristics (infiltrating, ductal grade, hormone receptor-positive (HR+), human epidermal growth factor receptor, triple negative, size, lymph node involvement, and clinical stage) were the dependent variables. Most of the women were postmenopausal (73.5%), with an infiltrating tumor (83.0%), HR+ (82.0%), and overweight or obese (71.0%). For the premenopausal women, obesity was associated with grade 3 ductal tumor (odds ratio (OR): 1.70; 95% confidence interval (95% CI): 1.09–2.66), triple negative (OR: 1.37, 95% CI: 1.08–3.24), and size ≥ 2 cm (OR: 2.20, 95% CI: 1.36–3.56). For the postmenopausal women, obesity was associated with WHR, infiltrating tumor (OR: 1.73, 95% CI: 1.56–1.95), size ≥ 2 cm (OR: 1.38, 95% CI: 1.11–1.71), lymph node involvement (OR: 1.24, 95% CI: 1.02–1.56), and stages III–IV (OR: 1.76, 95% CI: 1.30–2.65). Excess body weight and central adiposity were associated with tumor aggressiveness characteristics in women with breast cancer, confirming the importance of nutritional status.
Funder
Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro
National Council for Scientific and Technological Development
Subject
Food Science,Nutrition and Dietetics
Reference29 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;CA Cancer J. Clin.,2021
2. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) (2022, March 30). Estimativa 2020: Incidência de Câncer no Brasil, (In Portuguese).
3. Bougaret, L., Delort, L., Billard, H., Le OKHuede, C., Boby, C., De La Foye, A., Rossary, A., Mojallal, A., Damour, O., and Auxenfans, C. (2018). Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen. PLoS ONE, 13.
4. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention;CA Cancer J. Clin.,2017
5. World Health Organization (WHO) (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, World Health Organization. Available online: https://apps.who.int/iris/handle/10665/42330.